Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Surgery: selective bladder-preserving therapy for muscle-invasive cancer.

Heney NM, Kaufman DS, Shipley WU.

Nat Rev Clin Oncol. 2009 Apr;6(4):193-4. doi: 10.1038/nrclinonc.2009.21. No abstract available.

PMID:
19333224
2.

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL.

J Clin Oncol. 2014 Dec 1;32(34):3801-9. doi: 10.1200/JCO.2014.57.5548. Epub 2014 Nov 3. Erratum in: J Clin Oncol. 2015 Mar 1;33(7):814.

3.

[Radiochemotherapeutic options for bladder cancer].

Weiss C, Sauer R, Rödel C.

Aktuelle Urol. 2008 Mar;39(2):123-9. doi: 10.1055/s-2008-1038150. Review. German.

PMID:
18379965
4.

[Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].

Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.

Arch Esp Urol. 1997 Jun;50(5):448-54; discussion 454-6. Spanish.

PMID:
9382586
5.

Bladder-sparing therapy for muscle-infiltrating bladder cancer.

Pansadoro V, Emiliozzi P.

Nat Clin Pract Urol. 2008 Jul;5(7):368-75. doi: 10.1038/ncpuro1145. Epub 2008 Jun 17. Review.

PMID:
18560383
6.

[Alternating radiochemotherapy in bladder carcinomas].

Dunst J.

Strahlenther Onkol. 1998 Jun;174(6):335-6. German. No abstract available.

PMID:
9645218
7.

[Update on treatment of bladder cancer].

Visockiene R, Inciūra A, Juozaityte E.

Medicina (Kaunas). 2004;40(12):1239-48. Review. Lithuanian.

8.

Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.

Onozawa M, Miyanaga N, Hinotsu S, Miyazaki J, Oikawa T, Kimura T, Takaoka E, Kawai K, Shimazui T, Sakurai H, Nishiyama H, Akaza H.

Jpn J Clin Oncol. 2012 Sep;42(9):825-30. doi: 10.1093/jjco/hys105. Epub 2012 Jul 10.

PMID:
22782963
9.

Bladder preservation by combined modality therapy for invasive bladder cancer.

Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU.

J Clin Oncol. 1997 Mar;15(3):1022-9.

PMID:
9060542
10.

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

Shipley WU, Kaufman DS, Zehr E, Heney NM, Lane SC, Thakral HK, Althausen AF, Zietman AL.

Urology. 2002 Jul;60(1):62-7; discussion 67-8.

PMID:
12100923
11.

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M.

Urology. 2004 Jan;63(1):73-7. Review.

PMID:
14751352
12.

Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.

Choueiri TK, Raghavan D.

Nat Clin Pract Oncol. 2008 Aug;5(8):444-54. doi: 10.1038/ncponc1159. Epub 2008 Jun 24. Review.

PMID:
18577983
13.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
14.

[Combined therapy for patients with invasive bladder cancer].

Startsev VIu, Karelin MI.

Vopr Onkol. 2003;49(2):235-8. Russian.

PMID:
12785212
15.

Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).

Lagrange JL, Bascoul-Mollevi C, Geoffrois L, Beckendorf V, Ferrero JM, Joly F, Allouache N, Bachaud JM, Chevreau C, Kramar A, Chauvet B; Study Group on Genito-Urinary Tumors.

Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):172-8. doi: 10.1016/j.ijrobp.2009.10.038. Epub 2010 Apr 10.

PMID:
20385453
16.

Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Heinzelmann F, Thorwarth D, Lamprecht U, Kaulich TW, Fuchs J, Seitz G, Ebinger M, Handgretinger R, Bamberg M, Weinmann M.

Strahlenther Onkol. 2011 Nov;187(11):715-21. doi: 10.1007/s00066-011-2261-3. Epub 2011 Oct 29.

PMID:
22037652
17.

What is the role of radiotherapy in bladder-preserving cancer therapy?

Rödel C, Sauer R.

Nat Clin Pract Oncol. 2005 Jan;2(1):4-5. No abstract available.

PMID:
16264831
18.
19.

Bladder preservation: optimizing radiotherapy and integrated treatment strategies.

Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU.

BJU Int. 2008 Nov;102(9 Pt B):1345-53. doi: 10.1111/j.1464-410X.2008.07981.x. Review.

PMID:
19035903
20.

Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.

Koga F, Kihara K.

Int J Urol. 2012 May;19(5):388-401. doi: 10.1111/j.1442-2042.2012.02974.x. Epub 2012 Mar 12. Review.

Supplemental Content

Support Center